Literature DB >> 30527837

Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.

Nathalie Sermondade1, Charlotte Sonigo2, Christophe Sifer3, Sophie Valtat4, Marianne Ziol5, Florence Eustache3, Michaël Grynberg6.   

Abstract

OBJECTIVE: To assess whether serum antimüllerian hormone (AMH) levels and antral follicle count (AFC) can predict primordial follicle density within ovarian cortex and the number of oocytes cryopreserved after in vitro maturation (IVM).
DESIGN: Retrospective analysis of a case series of patients.
SETTING: University hospital. PATIENT(S): Fifty-four women, 18 to 35 years of age, with breast cancer who were candidates for fertility preservation (FP) using ovarian tissue cryopreservation (OTC) associated with oocyte vitrification after unstimulated IVM between July 2013 and December 2016. INTERVENTION(S): Serum AMH levels and transvaginal AFC evaluated before FP, cumulus-oocyte complexes (COC) recovered under ultrasound guidance and incubated for IVM, and ovarian tissue laparoscopically harvested and cryopreserved. MAIN OUTCOME MEASURE(S): Univariate and multivariate analysis between ovarian reserve tests, number of recovered and in vitro matured oocytes, and primordial follicle density histologically obtained within ovarian cortex. RESULT(S): Univariate analysis showed a statistically significant correlation between AMH or AFC and primordial follicle density. Multivariate analysis showed a predominant statistically significant correlation of serum AMH with density. Antimüllerian hormone also correlated with the number of COC and in vitro matured oocytes. CONCLUSION(S): Serum AMH levels may reflect the primordial follicle stockpile and may predict outcomes of IVM and OTC when performed for FP. Further analyses are required to evaluate the relevance of performing such procedures in young women who have low values on ovarian reserve tests.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMH; follicle density; in vitro maturation; ovarian tissue cryopreservation

Mesh:

Substances:

Year:  2018        PMID: 30527837     DOI: 10.1016/j.fertnstert.2018.10.018

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  A Systematic Review of Ovarian Tissue Transplantation Outcomes by Ovarian Tissue Processing Size for Cryopreservation.

Authors:  Ashley A Diaz; Hana Kubo; Nicole Handa; Maria Hanna; Monica M Laronda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

Review 2.  Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.

Authors:  Ewa Rudnicka; Michał Kunicki; Anna Calik-Ksepka; Katarzyna Suchta; Anna Duszewska; Katarzyna Smolarczyk; Roman Smolarczyk
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

3.  Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.

Authors:  Nathalie Sermondade; Michaël Grynberg; Marjorie Comtet; Constance Valdelievre; Christophe Sifer; Charlotte Sonigo
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

Review 4.  Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.

Authors:  Loes M E Moolhuijsen; Jenny A Visser
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.